GWW
41
2
AIG
83
3
V
46
2
CMG
50
7
PYPL
33
8
TXN
35
3
MNST
61
2
CFG
50
14
NWS
66
4
PNW
73
2
GS
49
4
APA
34
2
F
55
3
ADBE
44
4
LLY
59
-3
WEC
82
4
ACN
29
-4
BLK
49
3
SWKS
44
2
PAYX
44
2
GWW
41
2
AIG
83
3
V
46
2
CMG
50
7
PYPL
33
8
TXN
35
3
MNST
61
2
CFG
50
14
NWS
66
4
PNW
73
2
GS
49
4
APA
34
2
F
55
3
ADBE
44
4
LLY
59
-3
WEC
82
4
ACN
29
-4
BLK
49
3
SWKS
44
2
PAYX
44
2
Financhill
Back

Emergent BioSolutions 10K Form

Sell
14

EBS
Emergent BioSolutions

Last Price:
$5.71
Seasonality Move:
5.31%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-02 10Q EBS/Emergent BioSolutions Quarterly
2023-12-11 10Q EBS/Emergent BioSolutions Quarterly
2023-08-09 10Q EBS/Emergent BioSolutions Quarterly
2023-05-10 10Q EBS/Emergent BioSolutions Quarterly
2022-11-09 10Q EBS/Emergent BioSolutions Quarterly
2022-08-02 10Q EBS/Emergent BioSolutions Quarterly

Receive EBS News And Ratings

See the #1 stock for the next 7 days that we like better than EBS

EBS Financial Statistics

Sales & Book Value

Annual Sales: $1B
Cash Flow: $-81.6M
Price / Cash Flow: 8.56
Annual Sales: $8.89
Price / Book: 0.64

Profitability

EPS (TTM): -3.73000
Net Income (TTM): $-190.6M
Gross Margin: $332.3M
Return on Equity: -35.42%
Return on Assets: -11.9%

Emergent BioSolutions Earnings Forecast

Key Emergent BioSolutions Financial Ratios

  • The Gross Profit Margin over the past 23 years for EBS is 32.78%.
  • The Selling, General & Administrative Expenses for EBS have been equal to 30.39% of Gross Profit Margin.
  • The Research & Development expenses have been 6.98% of Revenue.
  • The Net Earning history of EBS is -18.80% of Total Revenues.
  • Per Share Earnings over the last 24 years have been positive in 13 years.

Emergent BioSolutions Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Biotechnology
Sector: Health Care
Current Symbol: EBS
CUSIP: 29089Q
Website: emergentbiosolutions.com

Debt

Debt-to-Equity Ratio: 1.37
Current Ratio: 3.69
Quick Ratio: 1.56

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 3.75

EBS Technical Analysis vs Fundamental Analysis

Sell
14
Emergent BioSolutions (EBS) is a Sell

Is Emergent BioSolutions a Buy or a Sell?